Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant

Journal of Lipid Research

Volumn 40, Issue 9, 1999, Pages 1663-1670

  Mero, Niina ^a   Suurinkeroinen, Leena ^a   Syvänne, Mikko ^a   Knudsen, Petteri ^a   Yki Järvinen, Hannele ^a   Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atherosclerosis; Lipoprotein lipase gene; Postprandial lipemia; Triglyceride rich lipoproteins; Whole body insulin sensitivity

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC DISORDER; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0032822705     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192.
2. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6: 291-305.
3. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. J. Jacobs, S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15.
4. Austin, M. A., J. E. Hokanson, and K. L. Edwards. 1998. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81: 7B-12B.
5. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic and Molecular Basis of Inherited Disease. 7th edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1913-1932.
6. Murthy, V., P. Julien, and C. Gagne. 1996. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol. Ther. 70: 101-135.
7. Wittrup, H. H., A. Tybjaerg-Hansen, S. Abildgaard, R. Steffensen, P. Schnohr, and B. G. Nordestgaard. 1997. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk ot ischemic heart disease. J. Clin. Invent. 99: 1606-1613.
8. Gerdes, C., R. M. Fisher, V. Nicaud, J. Boer, S. E. Humphries, P. J. Talmud, and O. Faergeman. 1997. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations. Studies in the fasting and postprandial states; the European Atherosclerosis Research Studies. Circulation. 96: 733-740.
9. Reymer, P. W. A., E. Gagne, B. E. Groenemeyer, H. Zhang, I. Forsyth, H. Jansen, J. C. Seidell, D. Kromhout, J. Kastelein, and M. R. Hayden. 1995. A lipoprotein lipase mutation (Asn291 Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 10: 28-34.
10. 291→Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J. Lipid Res. 37: 727-738.
11. Fisher, R. M., F. Mailly, R. E. Peacock, A. Hamsten, M. Seed, J. S. Yudkin, U. Beisiegel, G. Feussner, G. Miller, S. E. Humpries, and P. J. Talmud. 1995. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36: 2104-2112.
12. Zhang, H., P. W. A. Reymer, M. Liu, I. J. Forsythe, B. E. Groenemever, J. Frochlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma. 1995. Patients with apoE3 deficiency (E2/2, E2/3 and E4/4) who manifest with hyperlipidemia have increased frequency of Asn 291→Ser mutation in the human LPL gene. Arterioscler. Thromb. Vasc. Biol. 15: 1695-1703.
13. Jemaa, R., F. Fumeron, O. Poirier, L. Lecerf, A. Evans, D. Arveiler, G. Luc, J-P. Camhou, J-M. Bard, and J-C. Fruchart. 1995. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J. Lipid Res. 36: 2141-2146.
14. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogeneis. J. Lipid Res. 37: 693-707.
15. Peacock, R. E., A. Hamsten, P. Nilsson-Ehle, and S. Humphries. 1992. Associations between lipoprotein lipase gene polymorhisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 97: 171-185.
16. Benlian, P., J. L. De Gennes, L. Foubert, H. Zhang, S. E. Gagne, and M. Hayden. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854.
17. Pimstone, S. N., S. M. Glee, S. E. Gagne, L. Miao, H. Zhang, E. A. Stein, and M. R. Hayden. 1996. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J. Lipid Res. 37: 1675-1684.
18. Knudsen, P., S. Murtomaki, M. Antikainen, S. Ehnholm, S. Lahdenperä, C. Ehnholm, and M. R. Taskinen. 1997. The Asn-291→ Ser and Ser-477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia. Eur. J. Clin. Invest. 27: 928-935.
19. Syvänen, A-C., A. Sajantila, and M. Lukka. 1993. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am. J. Hum. Genet. 52: 46-59.
20. Mullis, K. B., and F. A. Faloona. 1987. Specific synthesis of DNA in vitro via polymerase-catalyzed chain reaction. Methods Enzymol. 155: 335-350.
21. Mero, N., M. Syvänne, M. Rosseneu, C. Labeur, H. Hilden, and M-R. Taskinen. 1998. Comparison of three fatty meals in healthy normolipidemic men: high post-prandial retinyl ester response to soybean oil. Eur. J. Clin. Invest. 28: 407-415.
22. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
23. Karpe, F., M. Bell, J. Björkegren, and A. Hamsten. 1995. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler. Thromb. Vasc. Biol. 15: 199-207.
24. DeFronzo, R. A., J. D. Tobin, and R. Andres. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-E223.
25. Yki-Järvinen, H., A. Consoli, N. Nurjhan, A. Young, and J. E. Gerich. 1989. Mechanism for underestimation of isotopically determined glucose disposal. Diabetes. 38: 744-751.
26. Huttunen J. K., C. Ehnholm, P. K. J. Kinnunen, and E. A. Nikkilä. 1975. An immunochemical method for selective measurement of two triglyceride lipases in human postheparin plasma. Clin. Chim. Acta. 63: 335-347.
27. Ikeda, Y., A. Takagi, Y. Ohkaru, K. Nogi, T. Iwanaga, S. Kurooka, and A. Yamamoto. 1990. A sandwich-enzyme immunoassay for quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. J. Lipid Res. 31: 1911-1924.
28. Antikainen, M., L. Suurinkeroinen, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen. 1996. Development and evaluation of an ELISA method for determination of lipoprotein lipase mass concentration - comparison with a commercial, one-step enzyme immunoassay. Eur. J. Clin. Chem. Clin. Biochem. 34: 547-553.
29. Ruotolo, G., Z. Huizhen, V. Bentsianov, and L. Ngoc-Anh. 1992. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J. Lipid Res. 33: 1541-1549.
30. Havekes, L. M., P. de Knijff, U. Beisiegel, J. Havinga, M. Smith, and E. Klasen. 1987. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid Res. 28: 455-463.
31. Kadish, A. H., R. L. Litle, and J. C. Sternberg. 1968. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin. Chem. 14: 116-131.
32. Miles, J., R. Glasscock, J. Aikens, J. Gerich, and M. Haymond. 1983. A microfluorometric method for the determination of free fatty acids in plasma. J. Lipid Res. 24: 96-99.
33. Ludbrook, J. 1994. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28: 303-311.
34. Matthews, J., D. Altman, M. Campbell, and P. Royston. 1990. Analysis of serial measurements in medical research. Brit. Med. J. 300: 230-235.
35. Schneeman, B. O., L. Kotite, K. M. Todd, and R. J. Havel. 1993. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Prof. Natl. Acad. Sci. USA. 90: 2069-2073.
36. Brunzell, J. D., W. R. Hazzard, D. Porte, Jr., and E. L. Bierman. 1973. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J. Clin. Invest. 52: 1578-1585.
37. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
38. Karpe, F., and M. Hultin. 1995. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J. Lipid Res. 36: 1557-1566.
39. Van Beek, A. P., H. H. J. J. van Barlingen, F. C. de Ruijter-Heijstek, H. Jansen, D. W. Erkelens, G. M. Dallinga-Thie, and T. W. A. de Bruin. 1998. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity. J. Lipid Res. 39: 322-332.
40. Stalenhoef, A. F., M. J. Malloy, J. P. Kane, and R. J. Havel. 1984. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc. Natl. Acad. Sci. USA. 81: 1839-1843.
41. Demant, T., A. Gaw, G. F. Watts, P. Durrington, B. Buckley, C. W. Imrie, C. Wilson, C. J. Packard, and J. Shepherd. 1993. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia. J. Lipid Res. 34: 147-156.
42. Malmström, R., C. J. Packard, T. D. G. Watson, S. Rannikko, M. Caslake, M. Bedford, P. Stewart, H. Yki-Järvinen, J. Shepherd, and M-R. Taskinen. 1997. Metabolic basis of hypertriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17: 1454-1464.
43. Malmström, R., C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Järvinen, J. Shepherd, and M.-R. Taskinen. 1997. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 40: 454-462.
44. Skottova, N., R. Savonen, A. Lookene, M. Hultin, and G. Olivecrona. 1995. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 36: 1334-1344.
45. Miesenböck, G., B. Hölzl, B. Föger, E. Brandstätter, B. Paulweber, F. Sandhofer, and J. R. Patsch. 1993. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J. Clin. Invest. 91: 448-455.
46. Sprecher, D. L., S. L. Knauer, D. M. Black, L. A. Kaplan, A. A. Akeson, M. Dusing, D. Lattier, E. A. Stein, M. Rymaszewski, and D. A. Wiginton. 1991. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J. Clin. Invest. 88: 985-994.
47. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80: 1571-1577.
48. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid Res. 29: 469-479.
49. O'Meara, N. M., G. F. Lewis, V. G. Cabana, P. H. Iverius, G. S. Getz, and K. S. Polonsky. 1992. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J. Clin. Endocrinol. Metab. 75: 465-471.
50. Castro, G. R., and C. J. Fielding. 1985. Effects of postprandial lipemia on plasma cholesterol metabolism. J. Clin. Invest. 75: 874-882.
51. Tall, A., D. Sammett, and E. Granot. 1986. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J. Clin. Invest. 77: 1163-1172.
52. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
53. Patsch, J., G. Miesenböck, T. Hopferwieser, V. Muhlberger, E. Knapp, J. Dunn, A. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12: 1336-1345.
54. Pimstone, S. N., S. E. Gagne, C. Gagne, P. J. Lupien, D. Gaudet, R. R. Williams, M. Kotze, P. W. A. Reymer, J. C. Defesche, J. J. P. Kastelein, S. Moorjani, and M. R. Hayden. 1995. Mutations in the gene for lipoprotein lipase: a cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15: 1704-1712.